Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Cosmos Health Inc. (COSM:NASDAQ), powered by AI.
Cosmos Health Inc. is currently trading at $0.21. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Cosmos Health Inc. on Alpha Lenz.
View Cosmos Health Inc.'s valuation metrics on Alpha Lenz.
“Cosmos Health Inc.'s ROE is -89.1%. Explore profitability and growth together.”
Ask for details →Cosmos Health Inc. is a global healthcare company specializing in the development, manufacturing, and distribution of pharmaceutical and nutraceutical products. Founded in 2009 and headquartered in Chicago, the company delivers a diverse portfolio that includes proprietary nutraceutical brands such as Sky Premium Life and Mediterranation, alongside a range of generic and over-the-counter medications. Cosmos Health’s operations extend internationally, with distribution capabilities reaching Europe, Asia, and North America, and subsidiaries in Greece and the United Kingdom facilitating its supply chain for retail pharmacies and wholesale distributors. The company’s product offerings cover medicines, dietary supplements, medical devices, and branded biocides, addressing the needs of healthcare providers, clinics, government agencies, and pharmacies. Cosmos Health is also actively involved in research and development, focusing on innovative nutraceutical formulas, patented specialized extracts, and complex generics. Through a commitment to quality, sustainability, and regulatory compliance, Cosmos Health Inc. plays a multifaceted role in the global healthcare distribution sector, contributing to the advancement of wellness and access to therapeutic products worldwide.
“Cosmos Health Inc.'s ROE is -89.1%. Explore profitability and growth together.”
Ask for details →Cosmos Health Inc. (ticker: COSM) is a company listed on NASDAQ in the Healthcare sector (Medical Distribution). It has approximately 149 employees.
The current price is $0.21 with a P/E ratio of -x and P/B of -x.
ROE is -89.13% and operating margin is -25.34%. Annual revenue is $65M.